Anatomic

Anatomic is a private, early-stage biotech company founded in 2019, operating at the intersection of digital health and diagnostics. The company has developed a proprietary platform that rapidly generates hiPSC-derived neural cells, including sensory neurons, motor neurons, and Schwann cell precursors, within seven days—a substantial acceleration over standard industry timelines. By selling cryopreserved cells, differentiation kits, and custom services, Anatomic aims to eliminate a key bottleneck in neurological research and drug discovery. Its business model is focused on providing tools and services to academic and industrial researchers, positioning it as an enabler rather than a therapeutic developer.

Proprietary hiPSC differentiation platform that generates Primal Ectoderm in 24 hours and functional immature neurons within 7 days, using directed differentiation in chemically defined conditions to create scalable, physiologically relevant neural cells.

Anatomic competes with other hiPSC service providers and cell vendors (e.g., Fujifilm Cellular Dynamics, Axol Bioscience), academic core facilities, and companies offering alternative neuronal models (e.g., primary cells, cell lines). Its main competitive edge is the claimed seven-day production timeline, but it must compete on cell quality, price, and reliability.